Next Post

JN Nova Pharma and NRC Human Health Group Partnership to Move Pan-COVID19 Therapeutic into Clinical Development

JN Nova Pharma is a private Canadian biotech company which has worked with an interdisciplinary team of researchers from the National Research Council of Canada’s (NRC) Human Health Therapeutics Research Centre over the past year to develop a promising anti-COVID-19 biotherapeutic with enhanced protection for vulnerable patients. Read More